Financial Navigation and Peer Support to Improve Diabetes Outcomes
Launched by UNIVERSITY OF MICHIGAN · Sep 27, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help people with diabetes manage their condition and the financial burdens that come with it. The study is testing a combined approach that includes financial help through technology and support from peers who understand the challenges of living with diabetes. Researchers want to see if this combination is more effective than just financial help alone in improving blood sugar levels (measured by A1c tests), blood pressure, and overall well-being.
To participate, you need to be between 18 and 75 years old, have a diabetes diagnosis, and currently be taking medication for it. You also should have had a recent A1c level above a certain point and be experiencing financial stress related to your diabetes care. Participants will complete surveys and health checks over the phone at the start of the study and again at 3 and 6 months. You'll be randomly assigned to either the financial help group or the group that also includes peer support. This trial is currently recruiting participants and aims to find out how effective this combined support can be in managing diabetes and improving quality of life.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Participants:
- • 18-75 years of age
- • diagnosis of diabetes with prescribed anti-hyperglycemic medication
- • most recent (within the past 6 months) recorded hemoglobin A1c (HbA1c) level of ≥7.5% for individuals ≤70 years and \>8.0% for individuals between 70-75 years in age
- • positive report of financial burden or cost-related non-adherence (CRN) using screening questions developed and validated from prior work 20-22
- • be willing to provide personal health information in order to effectively participate in the intervention
- Peer Supporters:
- • International Classification of Diseases (ICD)-10 code for diabetes
- • In the past had A1cs\' \> 8.0% but whose most recent A1c in the prior 12 months is \<8.0%.
- • Past experience with economic burden or unmet social risk factors
- • Adults 18-75 years
- Exclusion Criteria:
- Participants:
- • a diagnosis of a serious psychiatric disorder (e.g., schizophrenia)
- • active alcohol or illicit drug use
- • current pregnancy or planning pregnancy
- • taking a medication that alters glucose metabolism (e.g., oral steroids)
- • report a comorbidity expected to limit life span to \< 3 years
- • Participation in another diabetes study, but the investigators will ask them if they would like to be peer supporters
- Peer Supporters:
- • A diagnosis of a serious psychiatric disorder (e.g., schizophrenia)
- • Active alcohol or illicit drug use
- • Current pregnancy or planning pregnancy
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported